DNA origami-based nano-vaccines for cancer immunotherapy DOI Creative Commons
Tanvir Ahmed

Nano Trends, Год журнала: 2024, Номер 8, С. 100060 - 100060

Опубликована: Ноя. 16, 2024

Язык: Английский

Nanoparticles Enhancing Efficacy in Drug Formulation and Drug Delivery DOI
Tanvir Ahmed

Sustainable development and biodiversity, Год журнала: 2025, Номер unknown, С. 227 - 261

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Nanocarrier-based targeted drug delivery for Alzheimer’s disease: addressing neuroinflammation and enhancing clinical translation DOI Creative Commons
Kang Wang, Rui Yang, Jing Li

и другие.

Frontiers in Pharmacology, Год журнала: 2025, Номер 16

Опубликована: Май 14, 2025

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, amyloid-beta (Aβ) aggregation, tau pathology, and chronic neuroinflammation. Among these, neuroinflammation plays crucial role in exacerbating progression, making it an attractive therapeutic target. However, the presence of blood-brain barrier (BBB) significantly limits effective delivery agents to brain, necessitating novel drug strategies. Nanocarrier-based systems have emerged as promising solution these challenges, offering targeted transport, enhanced BBB penetration, improved bioavailability while minimizing systemic toxicity. This review explores current advancements nanocarrier-mediated for AD, focusing on mechanisms neuroinflammation, nanocarriers overcoming BBB, their ability modulate inflammatory pathways. Furthermore, discusses preclinical validation strategies key including safety concerns, large-scale production limitations, regulatory hurdles that must be addressed enable clinical translation. Future perspectives emphasize integration nanotechnology with precision medicine, gene therapy, artificial intelligence optimize nanocarrier design individualized AD treatment. By obstacles, hold potential revolutionize approaches other diseases.

Язык: Английский

Процитировано

0

Nanotechnology used for siRNA delivery for the treatment of neurodegenerative diseases: Focusing on Alzheimer’s disease and Parkinson’s disease DOI
Yan Li, Jiahui Zhang,

Boqin Ma

и другие.

International Journal of Pharmaceutics, Год журнала: 2024, Номер 666, С. 124786 - 124786

Опубликована: Окт. 6, 2024

Язык: Английский

Процитировано

1

On the Axonal Transport of Lipid Nanoparticles in Primary Hippocampal Neurons DOI Creative Commons
Ana M. Martins, Roberto Palomba, Michele Schlich

и другие.

Journal of Drug Delivery Science and Technology, Год журнала: 2024, Номер unknown, С. 106282 - 106282

Опубликована: Окт. 1, 2024

Язык: Английский

Процитировано

1

DNA origami-based nano-vaccines for cancer immunotherapy DOI Creative Commons
Tanvir Ahmed

Nano Trends, Год журнала: 2024, Номер 8, С. 100060 - 100060

Опубликована: Ноя. 16, 2024

Язык: Английский

Процитировано

1